Charles River signs partnership agreement with Bruker
Charles River to sell the Axcess System, a MALDI Biotyper solution for environmental monitoring applications
Charles River has entered into a partnership with Bruker to provide rapid, accurate microbial identifications to the industrial microbiology market, including pharmaceutical, biopharmaceutical, personal care and other manufacturing industries.
Through this agreement, the Charles River Endotoxin and Microbial Detection division will sell the Axcess System, an offering that combines the Bruker MALDI Biotyper system with a custom data analysis software solution that allows instantaneous access to the Accugenix microbial database for identifications.
By combining the precision and robustness of the Bruker MALDI Biotyper technology with the Accugenix cGMP compliant microbial database and software, the Axcess System can maximise performance for environmental monitoring applications while simplifying customers’ validation commitment. As the Accugenix database is frequently updated to reflect the inclusion of novel organisms relevant to industrial manufacturing facilities, customers will always have access to the most current and validated database for identifications, saving time and costs associated with validating library releases.
Included in the Axcess System offer, Charles River will provide sequence-based identifications for those isolates that fail to be identified by the MALDI Biotyper, minimising the customer’s need for a secondary system. By generating accurate and consistent microbial identification through this offer, manufacturing sites will be better able to reliably track and trend their facility for routine gridding studies or possible excursions.
‘We are delighted to be working with the Endotoxin and Microbial Detection division of Charles River on distribution of the MALDI Biotyper into the industrial and pharmaceutical microbiology markets. From my experience, the technical and sales teams that Charles River brings to this effort are among the best and most respected in these industries,’ said Dr Gary Kruppa, Vice President of Business Development at Bruker Daltonics.
‘With Charles River products in virtually every pharmaceutical microbiology laboratory, we are looking forward to working with Charles River to expand our efforts to make the MALDI Biotyper the new standard in microbial identification for industrial microbiology.’
‘By partnering with Bruker Daltonics, the recognised industry leader in MALDI-TOF mass spectrometry, we have reinforced our mutual commitment to meeting our customers’ microbial identification needs with innovative and comprehensive environmental monitoring solutions,’ added Foster Jordan, Corporate Senior Vice President, Charles River Endotoxin and Microbial Detection. ‘Our entire team here at Charles River is excited to introduce the Axcess System to the market and to represent the MALDI Biotyper by providing the same professionalism, responsiveness and expertise Bruker is known for.’
